A5017634951- Transplantation: Methods and Outcomes
- Heart Failure Treatment and Management
- Atrial Fibrillation Management and Outcomes
- Mechanical Circulatory Support Devices
- Renal Transplantation Outcomes and Treatments
- Cardiac Structural Anomalies and Repair
- Cardiovascular Issues in Pregnancy
- Adolescent and Pediatric Healthcare
- Cardiac pacing and defibrillation studies
- Automotive and Human Injury Biomechanics
- Cardiac Arrhythmias and Treatments
- Cardiovascular Function and Risk Factors
- Cardiac Imaging and Diagnostics
- COVID-19 Clinical Research Studies
- Cardiomyopathy and Myosin Studies
- Injury Epidemiology and Prevention
- Hepatitis C virus research
- Youth Education and Societal Dynamics
- Pregnancy and Medication Impact
- Cardiac Health and Mental Health
- Smart Parking Systems Research
- Organ Transplantation Techniques and Outcomes
- Muscle and Compartmental Disorders
- Organ and Tissue Transplantation Research
- Diabetes Treatment and Management
Columbia University Irving Medical Center
2020-2025
NewYork–Presbyterian Hospital
2020-2024
Texas Health Dallas
2024
Columbia University
2020-2024
Brigham and Women's Hospital
2024
New York Hospital Queens
2020-2022
Valve (United States)
2021-2022
University of Maryland, Baltimore
2017-2018
Background: Advanced heart failure therapies such as left ventricular assist device (LVAD) implantation require intricate follow-up and complex care. We sought to explore the burden of psychosocial risk factors among patients with LVAD their impact on postimplant outcomes using Interagency Registry for Mechanically Assisted Circulatory Support. Methods: Adult in Support requiring durable between 2008 2017 were included. Individuals determined have if they had one following: (1) limited...
Abstract Background There are limited data evaluating the success of a structured transition plan specifically for pediatric heart transplant (HT) recipients following their transfer care to an adult specialist. We sought identify risk factors poor adherence, graft failure, and mortality HT teams. Methods retrospectively reviewed all patients who underwent from program at our center between January 2011 June 2021. Demographic characteristics, comorbid conditions, psychosocial history were...
More women of childbearing age are surviving after heart transplantation (HT), many whom have a desire to become pregnant. Limited data exist evaluating patients' perspectives, receipt counseling, and knowledge surrounding contraception, pregnancy, breastfeeding, medication safety HT.
BACKGROUND: Cardiac allograft vasculopathy (CAV) leads to impaired myocardial blood flow (MBF), increasing the risk of cardiovascular death or retransplant among heart transplantation (HT) recipients. Data on elevation in donor-derived cell-free DNA (dd-cfDNA) and CAV absence rejection are mixed. We sought test hypothesis that with reduced MBF (RMBF) is associated elevated dd-cfDNA. METHODS: A retrospective review was conducted HT recipients at a high-volume center who underwent dd-cfDNA...
The use of glucagon-like-peptide 1 receptor agonists (GLP1-RA) has dramatically increased over the past 5 years for diabetes mellitus type 2 (T2DM) and obesity. These comorbidities are prevalent in adult heart transplant (HT) recipients. However, there limited data evaluating efficacy this drug class population. aim current study was to describe cardiometabolic changes HT recipients prescribed GLP1-RA at a large-volume center.